For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Search Close Search
Page Menu

Thomas J. Fitzgerald, MD

Research Focus - The Quality Assurance Review Center (QARC) and Radiation Biology of Tumor Resistance to Therapy and Normal Tissue Injury

  • Director and NCI primary investigator on quality assurance of imaging and radiation oncology clinical/translational oncology patient trials
  • Curation and archival storage of imaging data for artificial intelligence (AI) research
  • Research in radiation basic science for tumor control and tissue injury
  • Application of expertise in bone marrow biology for hematopoietic and leukemia/lymphoma stem cell populations
  • Study of cell adhesion molecules and the impact of anti-adhesion therapy as a co-partner to radiation therapy for epithelial disease

Representative Publication  

Wang T, Huang J, Vue M, et al. αvβ3 Integrin mediates radioresistance of prostate cancer cells through regulation of survivin. Mol Cancer Res. 2019;17(2):398-408.

Read Publication

More Publications